Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Amyloidosis (Phase 3)
Antigens, CD20 (Phase 1)
Antiphospholipid Syndrome (Phase 1)
Arthritis, Rheumatoid (Phase 1)
Autoimmune Diseases (Phase 2)
beta-Thalassemia (Phase 2)
Bone Marrow Cells (Phase 2)
Brain Neoplasms (Phase 3)
Breast Neoplasms (Phase 2)
Bronchopulmonary Dysplasia (Phase 1)
Burkitt Lymphoma (Phase 2)
Cardiomyopathies (Phase 2)
Cerebellar Diseases (Phase 2)
Cerebral Palsy (Phase 2)
Chromosome Aberrations (Phase 2)
Colonic Neoplasms (Phase 1)
Colorectal Neoplasms (Phase 1)
Coronary Artery Bypass (Phase 1/Phase 2)
Crohn Disease (Phase 2)
Diabetes Mellitus, Type 1 (Phase 2)
Diploidy (Phase 2)
Encephalitis (Phase 2)
Endocrine System Diseases (Phase 1/Phase 2)
Glioblastoma (Phase 2/Phase 3)
Glioma (Phase 1)
Gliosarcoma (Phase 1/Phase 2)
Glucose Metabolism Disorders (Phase 1/Phase 2)
Graft vs Host Disease (Phase 2)
Hamartoma (Phase 1)
Hematopoietic Stem Cell Transplantation (Phase 2)
HIV Infections (Phase 1/Phase 2)
Hodgkin Disease (Phase 2)
Immune System Diseases (Phase 1/Phase 2)
Infertility, Male (Phase 2)
Intestinal Neoplasms (Phase 2)
Intraocular Lymphoma (Early Phase 1)
Lambert-Eaton Myasthenic Syndrome (Phase 2)
Leukemia (Phase 3)
Leukemia, Eosinophilic, Acute (Phase 3)
Leukemia, Hairy Cell (Phase 1)
Leukemia, Large Granular Lymphocytic (Early Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia-Lymphoma, Adult T-Cell (Phase 1)
Leukemia, Monocytic, Acute (Phase 3)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2/Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myelomonocytic, Acute (Phase 3)
Leukemia, Plasma Cell (Phase 2)
Leukemia, Prolymphocytic (Phase 1/Phase 2)
Leukemia, Prolymphocytic, B-Cell (Phase 2)
Leukemia, Prolymphocytic, T-Cell (Phase 2)
Lupus Erythematosus, Systemic (Phase 3)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 1)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 1)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Peripheral (Early Phase 1)
Lymphomatoid Granulomatosis (Phase 1)
Medulloblastoma (Phase 3)
Melanoma (Phase 1)
Meningitis (Phase 1/Phase 2)
Metabolic Diseases (Phase 1/Phase 2)
Multiple Myeloma (Phase 3)
Multiple Sclerosis (Phase 2)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Myasthenia Gravis (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myocardial Infarction (Phase 3)
Neoplasm Metastasis (Phase 2/Phase 3)
Neoplasm, Residual (Phase 2)
Neoplasms (Phase 2)
Neuroblastoma (Phase 3)
Neuroectodermal Tumors (Phase 3)
Neuromyelitis Optica (Phase 2)
Opsoclonus-Myoclonus Syndrome (Phase 2)
Organ Transplantation (Phase 2)
Osteoarthritis, Hip (Phase 1)
Osteoarthritis, Knee (Phase 1)
Ovarian Neoplasms (Phase 2)
Pemphigus (Phase 1)
Peripheral Vascular Diseases (Phase 1)
Plasmablastic Lymphoma (Phase 1/Phase 2)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2/Phase 3)
Retinitis Pigmentosa (Phase 1/Phase 2)
Retinoblastoma (Phase 3)
Rhabdoid Tumor (Phase 3)
Sarcoidosis (Phase 1/Phase 2)
Sarcoma (Phase 3)
Scleroderma, Systemic (Phase 2)
Sezary Syndrome (Phase 1)
Spinal Cord Injuries (Phase 1/Phase 2)
Stem Cell Transplantation (Phase 2)
Stiff-Person Syndrome (Phase 2)
Teratoma (Phase 2)
Testicular Neoplasms (Phase 2)
Translocation, Genetic (Phase 2)
Transplantation, Autologous (Phase 2)
Transplantation, Homologous (Phase 2)
Vasculitis, Central Nervous System (Phase 2)
Waldenstrom Macroglobulinemia (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue